|
市場調査レポート
商品コード
1463671
中南米のバイオアナリシス検査サービス：2030年までの市場予測 - 地域分析 - サービス別、疾患適応症別、エンドユーザー別South & Central America Bioanalytical Testing Services Market Forecast to 2030 - Regional Analysis - by Services ; Disease Indication ; and End User |
||||||
|
|
|||||||
|
|||||||
| 中南米のバイオアナリシス検査サービス：2030年までの市場予測 - 地域分析 - サービス別、疾患適応症別、エンドユーザー別 |
|
出版日: 2024年02月05日
発行: The Insight Partners
ページ情報: 英文 100 Pages
納期: 即納可能
 |
- 全表示
- 概要
- 図表
- 目次
中南米のバイオアナリシス検査サービス市場は、2022年に2億4,243万米ドルと評価され、2030年には4億9,176万米ドルに達すると予測され、2022年から2030年までのCAGRは9.2%で成長すると推定されます。
製薬産業の絶え間ない成長が中南米のバイオ分析試験サービス市場に拍車をかける
医薬品やその他の医薬品の研究開発、生産、流通は、医薬品産業の主要分野です。世界の医薬品消費量は、加齢関連疾患や慢性疾患の治療薬に対するニーズの高まりとともに増加しています。WHOによると、60歳以上の高齢者人口は2020年から2050年にかけて倍増し、2050年には21億人に達すると予測されています。高齢者人口の増加は、心血管疾患、がん、高血圧、変形性関節症、糖尿病などの慢性疾患の発生を急増させる。そのため、慢性疾患は製薬会社の主要な注力分野となっています。新薬の開発は、資源、コスト、時間を要するプロセスであり、臨床段階が遅れると多大なコストがかかります。いくつかの製薬会社は、臨床段階と前臨床段階の両方において、医薬品開発とアッセイのバリデーションにバイオ分析試験サービスを選択しています。ジェネリック医薬品と先発医薬品は、ほとんどが低分子化合物です。ジェネリック医薬品メーカーは、特許失効の問題を克服するためにバイオ分析試験結果を実施し、提出します。このように、製薬産業の絶え間ない増殖に伴い、バイオ分析試験サービス・プロバイダーは、将来そのサービスに対する需要が継続的に増加する可能性が高く、バイオ分析試験サービス市場の新たな成長機会につながると思われます。
中南米のバイオアナリシス検査サービス市場概要
中南米のバイオアナリシス検査サービス市場は、ブラジル、アルゼンチン、その他中南米に細分化されます。この地域の市場成長は、病気に対する意識の高まりや各国のヘルスケア支出の増加とともに、この地域でのプレゼンスを確立しようとする世界の製薬会社の継続的な取り組みが主な要因です。
中南米のバイオアナリシス検査サービス市場の収益と2030年までの予測（金額）
中南米のバイオアナリシス検査サービス市場セグメンテーション
中南米のバイオアナリシス検査サービス市場は、検査タイプ、疾患適応症、エンドユーザー、国によって区分されます。
検査タイプ別では、中南米のバイオアナリシス検査サービス市場は、薬物動態学、バイオマーカー、免疫原性、ウイルス学検査、細胞ベースアッセイ、その他に区分されます。2022年には、セルベースアッセイ部門が最大の市場シェアを占めました。
疾患適応症に基づき、中南米のバイオアナリシス検査サービス市場は、心血管、神経疾患、代謝疾患、呼吸器疾患、自己免疫疾患、腫瘍学、性の健康、骨疾患、その他に区分されます。2022年の市場シェアは、がん分野が最大でした。
エンドユーザー別に見ると、中南米のバイオアナリシス検査サービス市場は、製薬・バイオ医薬品企業、研究開発受託機関（CRO）、開発・製造受託機関（CDMO）、その他に区分されます。製薬・バイオ製薬企業セグメントが2022年に最大の市場シェアを占めました。
国別に見ると、中南米のバイオアナリシス検査サービス市場は、ブラジル、アルゼンチン、その他中南米に区分されます。2022年の中南米のバイオ分析試験サービス市場シェアは、ブラジルが独占しました。
SGS SA、Pharmaron Beijing Co Ltd、Element Materials Technology Group Ltd、Charles River Laboratories International Inc、Eurofins Scientific SE、Labcorp Drug Development Inc、Syneos Health Inc、ICON Plc、Intertek Group Plcは、中南米バイオ分析試験サービス市場で事業を展開する大手企業の一部です。
目次
目次
第1章 イントロダクション
第2章 エグゼクティブサマリー
- 主要洞察
第3章 調査手法
- 調査範囲
- 2次調査
- 1次調査
第4章 中南米のバイオ分析試験サービス市場情勢
- PEST分析
- 中南米のPEST分析
第5章 中南米のバイオアナリシス検査サービス市場：主要産業力学
- 主な市場促進要因
- 製薬企業による研究開発活動のアウトソーシングの増加
- バイオシミラーおよび生物製剤の分析試験に対する高い需要
- 主な市場抑制要因
- バイオ分析試験サービスに関連する高コスト
- 主な市場機会
- 製薬産業の持続的成長
- 今後の動向
- 新興・希少疾患に対する創薬・開発活動の活発化
- インパクト分析
第6章 バイオアナリシス検査サービス市場：中南米市場分析
- バイオアナリシス検査サービス市場収益、2022年～2030年
第7章 中南米のバイオアナリシス検査サービス市場 - 収益と2030年までの予測：サービス別
- 市場収益シェア、2022年および2030年
- 薬物動態学
- バイオマーカー
- 免疫原性
- ウイルス検査
- 細胞ベースアッセイ
- その他
第8章 中南米のバイオアナリシス検査サービス市場 - 収益と2030年までの予測：適応疾患別
- 市場収益シェア、2022年および2030年
- 心血管疾患
- 神経疾患
- 代謝疾患
- 腫瘍学
- 性の健康
- 骨疾患
- その他
第9章 中南米のバイオアナリシス検査サービス市場 - 収益と2030年までの予測：エンドユーザー別
- 市場収益シェア、2022年および2030年
- 製薬会社およびバイオ医薬品会社
- 開発業務受託機関（CRO）
- 開発製造受託機関（CDMO）
- その他
第10章 中南米のバイオアナリシス検査サービス市場：国別分析
- ブラジル
- アルゼンチン
- その他中南米
第11章 バイオアナリシス検査サービス市場業界情勢
- バイオアナリシス検査サービス市場の成長戦略
- 無機的成長戦略
- 有機的成長戦略
第12章 企業プロファイル
- SGS SA
- Pharmaron Beijing Co Ltd
- Element Materials Technology Group Ltd
- Charles River Laboratories International Inc
- Eurofins Scientific SE
- Labcorp Drug Development Inc
- Syneos Health Inc
- ICON Plc
- Intertek Group Plc
第13章 付録
List Of Tables
- Table 1. South & Central America Bioanalytical Testing Services Market Segmentation
- Table 2. Brazil Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn) - Services
- Table 3. Brazil Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn) - Virology Testing
- Table 4. Brazil Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn) - Disease Indication
- Table 5. Brazil Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
- Table 6. Argentina Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
- Table 7. Argentina Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
- Table 8. Argentina Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
- Table 9. Argentina Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
- Table 10. Rest of South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
- Table 11. Rest of South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
- Table 12. Rest of South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
- Table 13. Rest of South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
- Table 14. Recent Inorganic Growth Strategies in the Bioanalytical Testing Services Market
- Table 15. Recent Organic Growth Strategies in the Bioanalytical Testing Services Market
- Table 16. Glossary of Terms, South & Central America Bioanalytical Testing Services Market
List Of Figures
- Figure 1. South & Central America Bioanalytical Testing Services Market Segmentation, By Country
- Figure 2. South & Central America - PEST Analysis
- Figure 3. South & Central America Bioanalytical Testing Services Market - Key Industry Dynamics
- Figure 4. Impact Analysis of Drivers and Restraints
- Figure 5. South & Central America Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 - 2030
- Figure 6. South & Central America Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
- Figure 7. Pharmacokinetics: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 8. Biomarkers: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 9. Immunogenicity: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 10. Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 11. In-Vitro Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 12. In-Vivo Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 13. Cell-Based Assays: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 14. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 15. South & Central America Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
- Figure 16. Cardiovascular: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 17. Neurological Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 18. Metabolic Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 19. Oncology: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 20. Sexual Health: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 21. Bone Disease: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 22. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 23. South & Central America Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
- Figure 24. Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 25. Contract Research Organization (CRO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 26. Contract Development and Manufacturing Organization (CDMO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 27. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 28. South & Central America Bioanalytical Testing Services Market, By Country, 2022 ($Mn)
- Figure 29. South & Central America Bioanalytical Testing Services Market, By Key Countries, 2022 And 2030 (%)
- Figure 30. Brazil Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
- Figure 31. Argentina Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
- Figure 32. Rest of South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
- Figure 33. Growth Strategies in the Bioanalytical Testing Services Market
The South & Central America bioanalytical testing services market was valued at US$ 242.43 million in 2022 and is expected to reach US$ 491.76 million by 2030; it is estimated to grow at a CAGR of 9.2% from 2022 to 2030.
Uninterrupted Growth of Pharmaceuticals Industry Fuel the South & Central America Bioanalytical Testing Services Market
The research & development, production, and distribution of medicinal drugs and other pharmaceutical products are the major areas of the pharmaceutical industry. Global pharmaceutical consumption is rising with the increasing need for drugs to treat age-related diseases and chronic diseases. According to the WHO, the elderly population aged 60 or above is projected to double from 2020 to 2050, reaching ~2.1 billion by 2050. A rise in the geriatric population would contribute to a surge in incidences of chronic diseases, such as cardiovascular diseases, cancer, hypertension, osteoarthritis, and diabetes mellitus. Thus, chronic diseases have been a major area of focus for pharmaceutical companies. New drug development is a resource-, cost-, and time-intensive process, where later clinical stages result in significant costs. Several pharmaceutical companies are opting for bioanalytical testing services for drug development and validation of assays in both clinical and preclinical stages. Generics and branded drug compounds are mostly small molecules. Generics manufacturers conduct and submit bioanalytical testing results to overcome the issue of patent expiration. Thus, with the uninterrupted proliferation of the pharmaceutical industry, bioanalytical testing service providers are likely to experience a continuous rise in demand for their services in the future, which would lead to new growth opportunity in the bioanalytical testing services market.
South & Central America Bioanalytical Testing Services Market Overview
The bioanalytical testing services market in South & Central America is sub segmented into Brazil, Argentina, and the Rest of South & Central America. The market growth in this region is primarily attributed to the ongoing efforts of global pharmaceutical companies to establish their presence in the region, along with the increasing awareness about diseases and rising healthcare expenditure by countries.
South & Central America Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Bioanalytical Testing Services Market Segmentation
The South & Central America bioanalytical testing services market is segmented based on test type, disease indication, end user, and country.
Based on test type, the South & Central America bioanalytical testing services market is segmented into pharmacokinetics, biomarkers, immunogenicity, virology testing, cell-based assays, and others. The cell-based assays segment held the largest market share in 2022.
Based on disease indication, the South & Central America bioanalytical testing services market is segmented into cardiovascular, neurological disorders, metabolic disorders, respiratory diseases, autoimmune disorder, oncology, sexual health, bone disease, and others. The oncology segment held the largest market share in 2022.
Based on end user, the South & Central America bioanalytical testing services market is segmented into pharmaceutical and biopharmaceutical companies, contract research organization (CRO), contract development and manufacturing organization (CDMO), and others. The pharmaceutical and biopharmaceutical companies segment held the largest market share in 2022.
Based on country, the South & Central America bioanalytical testing services market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America bioanalytical testing services market share in 2022.
SGS SA, Pharmaron Beijing Co Ltd, Element Materials Technology Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Labcorp Drug Development Inc, Syneos Health Inc, ICON Plc, and Intertek Group Plc are some of the leading companies operating in the South & Central America bioanalytical testing services market.
Table Of Contents
Table of Content
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Key Insights
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. South & Central America Bioanalytical Testing Services Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 South & Central America PEST Analysis
5. South & Central America Bioanalytical Testing Services Market - Key Industry Dynamics
- 5.1 Key Market Drivers:
- 5.1.1 Increasing Outsourcing of R&D Activities by Pharmaceutical Companies
- 5.1.2 High Demand for Analytical Testing of Biosimilars and Biologics
- 5.2 Key Market Restraints:
- 5.2.1 High Cost Associated to Bioanalytical Testing Services
- 5.3 Key Market Opportunities
- 5.3.1 Uninterrupted Growth of Pharmaceuticals Industry
- 5.4 Future Trends
- 5.4.1 Rising Drug Discovery and Development Activities for Emerging and Rare Diseases
- 5.5 Impact Analysis:
6. Bioanalytical Testing Services Market - South & Central America Market Analysis
- 6.1 Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 - 2030
7. South & Central America Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Services
- 7.1 Overview
- 7.2 Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
- 7.3 Pharmacokinetics
- 7.3.1 Overview
- 7.3.2 Pharmacokinetics: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4 Biomarkers
- 7.4.1 Overview
- 7.4.2 Biomarkers: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- 7.5 Immunogenicity
- 7.5.1 Overview
- 7.5.2 Immunogenicity: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- 7.6 Virology Testing
- 7.6.1 Overview
- 7.6.2 Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- 7.6.2.1 In-Vitro Virology Testing
- 7.6.2.1.1 Overview
- 7.6.2.2 In-Vitro Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- 7.6.2.1 In-Vitro Virology Testing
- 7.6.3 In-Vivo Virology Testing
- 7.6.3.1 Overview
- 7.6.3.2 In-Vivo Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- 7.7 Cell-Based Assays
- 7.7.1 Overview
- 7.7.2 Cell-Based Assays: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- 7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Disease Indication
- 8.1 Overview
- 8.2 Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
- 8.3 Cardiovascular
- 8.3.1 Overview
- 8.3.2 Cardiovascular: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4 Neurological Diseases
- 8.4.1 Overview
- 8.4.2 Neurological Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- 8.5 Metabolic Disorders
- 8.5.1 Overview
- 8.5.2 Metabolic Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- 8.6 Oncology
- 8.6.1 Overview
- 8.6.2 Oncology: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- 8.7 Sexual Health
- 8.7.1 Overview
- 8.7.2 Sexual Health: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- 8.8 Bone Disease
- 8.8.1 Overview
- 8.8.2 Bone Disease: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- 8.9 Others
- 8.9.1 Overview
- 8.9.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by End User
- 9.1 Overview
- 9.2 Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
- 9.3 Pharmaceutical and Biopharmaceutical Companies
- 9.3.1 Overview
- 9.3.2 Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- 9.4 Contract Research Organization (CRO)
- 9.4.1 Overview
- 9.4.2 Contract Research Organization (CRO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- 9.5 Contract Development and Manufacturing Organization (CDMO)
- 9.5.1 Overview
- 9.5.2 Contract Development and Manufacturing Organization (CDMO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- 9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Bioanalytical Testing Services Market - Country Analysis
- 10.1 South & Central America Bioanalytical Testing Services Market, Revenue and Forecast to 2030
- 10.1.1 Overview
- 10.1.1.1 South & Central America Bioanalytical Testing Services Market by Country
- 10.1.1.2 Brazil
- 10.1.1.2.1 Overview
- 10.1.1.2.2 Brazil Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.2.3 Brazil Bioanalytical Testing Services Market, by Services
- 10.1.1.2.3.1 Brazil Bioanalytical Testing Services Market, by Virology Testing
- 10.1.1.2.4 Brazil Bioanalytical Testing Services Market, by Disease Indication
- 10.1.1.2.5 Brazil Bioanalytical Testing Services Market, by End User
- 10.1.1.3 Argentina
- 10.1.1.3.1 Overview
- 10.1.1.3.2 Argentina Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.3.3 Argentina Bioanalytical Testing Services Market, by Services
- 10.1.1.3.3.1 Argentina Bioanalytical Testing Services Market, by Virology Testing
- 10.1.1.3.4 Argentina Bioanalytical Testing Services Market, by Disease Indication
- 10.1.1.3.5 Argentina Bioanalytical Testing Services Market, by End User
- 10.1.1.4 Rest of South & Central America
- 10.1.1.4.1 Overview
- 10.1.1.4.2 Rest of South & Central America Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.4.3 Rest of South & Central America Bioanalytical Testing Services Market, by Services
- 10.1.1.4.3.1 Rest of South & Central America Bioanalytical Testing Services Market, by Virology Testing
- 10.1.1.4.4 Rest of South & Central America Bioanalytical Testing Services Market, by Disease Indication
- 10.1.1.4.5 Rest of South & Central America Bioanalytical Testing Services Market, by End User
- 10.1.1 Overview
11. Bioanalytical Testing Services Market Industry Landscape
- 11.1 Overview
- 11.2 Growth Strategies in the Bioanalytical Testing Services Market
- 11.3 Inorganic Growth Strategies
- 11.3.1 Overview
- 11.4 Organic Growth Strategies
- 11.4.1 Overview
12. Company Profiles
- 12.1 SGS SA
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Pharmaron Beijing Co Ltd
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Element Materials Technology Group Ltd
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Charles River Laboratories International Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Eurofins Scientific SE
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Labcorp Drug Development Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Syneos Health Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 ICON Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 Intertek Group Plc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
13. Appendix
- 13.1 About Us
- 13.2 Glossary of Terms
